Erectile dysfunction & priapism
ED = failure to achieve/maintain an erection (vascular/neurogenic/endocrine/psychogenic/drugs); priapism = prolonged unwanted erection
Overview
Two ends of the erectile spectrum. Erectile dysfunction (ED) is the persistent inability to achieve or maintain an erection for satisfactory sex — frequently an early marker of cardiovascular disease or diabetes, so it warrants CV-risk assessment. Priapism is the opposite: a prolonged (>4 h) unwanted erection that is a urological EMERGENCY because the ischaemic form causes corporal necrosis and permanent impotence.
Recognise
- ED — organic clues: gradual onset, absent morning/spontaneous erections, vascular risk factors (diabetes, smoking, hypertension), drugs (beta-blockers, thiazides, SSRIs, antipsychotics), endocrine (low testosterone, hyperprolactinaemia)
- ED — psychogenic clues: sudden onset, situational, preserved morning erections, relationship/anxiety context; young man
- Priapism: painful persistent erection >4 h with a soft glans (ischaemic/low-flow — the emergency); causes — sickle cell disease, drugs (trazodone, intracavernosal agents, recreational), haematological malignancy, spinal cord injury
Red flags
- Priapism >4 h = urological EMERGENCY → aspiration ± intracavernosal phenylephrine without delay (ischaemia → permanent erectile dysfunction)
- New ED is a sentinel marker of cardiovascular disease/diabetes → assess and modify CV risk; don't co-prescribe a PDE5 inhibitor with nitrates
Differentials & how to tell them apart
Investigations
ED: history (organic vs psychogenic), examination (peripheral pulses, genitalia, prostate), bloods — fasting glucose/HbA1c, lipids, morning testosterone (± prolactin/LH/FSH and TFTs if low); assess cardiovascular risk. Priapism: cavernosal blood gas (ischaemic = hypoxic/acidotic, low-flow), FBC/sickle screen, identify the precipitant.
Management
ED → CV-risk assessment + PDE5 inhibitor (not with nitrates); priapism → emergency aspiration ± phenylephrine
- 1ED: distinguish organic from psychogenic (morning erections, onset, risk factors); check glucose/lipids/morning testosterone and assess cardiovascular risk; treat reversible causes and offer a PDE5 inhibitor.Gate: Do NOT co-prescribe a PDE5 inhibitor with nitrates/nicorandil (severe hypotension); new ED is a sentinel marker of cardiovascular disease — investigate and modify risk.
- 2Priapism >4 h is a urological EMERGENCY → cavernosal blood gas, then aspiration ± intracavernosal phenylephrine (and treat the cause — sickle cell, culprit drug); surgical shunt if refractory. Delay risks permanent impotence.
Key points
ED: organic (gradual, NO morning erections, vascular/diabetic/drug/endocrine) vs psychogenic (sudden, situational, morning erections preserved) → PDE5 inhibitor (NEVER with nitrates) + CV-risk assessment (ED is a sentinel CV marker). Priapism >4 h = EMERGENCY (sickle cell, trazodone) → aspiration ± phenylephrine before ischaemia causes permanent impotence.
Monitor & prognosis
ED: response/CV risk factors; priapism: detumescence, recurrence, the underlying cause.
ED treatable and a useful CV warning sign; ischaemic priapism risks permanent impotence if not treated promptly.
Source: NICE CKS (ED); BAUS (priapism); cross-ref cardiovascular/endocrine, child_health (sickle cell)